Pharmaceutical
OCP reports neuropathic progress in pre-clinical trials
Promising results reported from studies testing the efficacy of its lead compound.
Andrew Mernin
21stories
31 Marlast updated
More in Andrew Mernin
- Medical
Why Tyson’s celebrity cannabis empire is fighting fit
Former boxer’s plan to build a stable of celebrity branded products takes shape.
- Adult-Use
Agreement reached for landmark Columbia Care deal
Columbia Care is to be acquired by Cresco Labs in a deal which will create the world’s “largest cannabis company by revenue”.
- Uncategorized
Will NFTs shape the future of cannabis events?
A US-based cannabis events firm is harnessing the metaverse and non-fungible tokens (NFTs) to build its global audiences.
- Adult-Use
Aurora growth bolstered in latest acquisition
Aurora Cannabis is to acquire fellow Canadian firm Thrive for an initial value of US$38m plus earn out amounts over the next two years.
- News
Kanabo agreement to create ‘Europe’s largest public cannabis company’
Materia deal will accelerate listed firm’s ongoing progress.
- Medical
Khiron Visualises Brazilian growth after landmark product sale
The European medical cannabis group Khiron is aiming to use its first product sales in Brazil as a launchpad for South American growth.
- News
US takeover opens new chapter for Taylor Mammon
The UK CBD manufacturer Taylor Mammon is has been bought by US firm GenCanna.
